29 results
8-K
EX-99.1
AGIO
Agios Pharmaceuticals Inc
28 Oct 19
Agios Presents Data from Single Agent Dose-Escalation Arm of Phase 1 Study ofAG-270, a MAT2A Inhibitor, in Patients withMTAP-Deleted Tumors
7:20am
Tumors
– Plasma SAM Biomarker Indicates Robust Target Engagement at Well Tolerated Doses;AG-270 Maximum Tolerated Dose Determined to be 200 mg Once
8-K
EX-99.1
AGIO
Agios Pharmaceuticals Inc
3 Nov 21
Agios Reports Business Highlights and Third Quarter 2021 Financial Results
7:27am
cell disease, as well as disease education and engagement efforts for mitapivat in PK deficiency, thalassemia and sickle cell disease.
Selling
8-K
EX-99.1
AGIO
Agios Pharmaceuticals Inc
30 Jul 20
Agios Reports Business Highlights and Second Quarter 2020 Financial Results
7:17am
build of the company’s European operations offset by reduced travel and industry engagement given restrictions in place to combat the COVID-19
8-K
EX-99.2
AGIO
Agios Pharmaceuticals Inc
4 May 18
Results of Operations and Financial Condition
7:07am
2017
Evaluate evidence of target engagement showing 2-HG suppression in brain tumor tissue IDH1m Low Grade Glioma Patients Eligible for Resection … Engagement 4 weeks Study Objectives: Determine amount of drug penetration in the brain Confirm magnitude of IDHm target engagement as measured by 2HG
DEFM14A
AGIO
Agios Pharmaceuticals Inc
11 Feb 21
Proxy related to merger
4:19pm
as financial advisor to Agios in connection with the engagement of Goldman Sachs as financial advisor in connection with the proposed transaction with Servier … advisor to Agios in connection with the engagement of Morgan Stanley as financial advisor to Agios in connection with the proposed transaction
PREM14A
iqcq1ax7akquba474
29 Jan 21
Preliminary proxy related to merger
4:22pm
8-K
EX-99.1
0jv trzh03nhvpto64f
16 Oct 15
Regulation FD Disclosure
12:00am
424B4
gfgonis
24 Apr 14
Prospectus supplement with pricing info
12:00am
8-K
EX-2.1
la4m0lu
21 Dec 20
Entry into a Material Definitive Agreement
9:15pm
DEFA14A
EX-2.1
xtlg1ad9 b5pc5r2
21 Dec 20
Additional proxy soliciting materials
9:17pm